Interface between tauopathies and synucleinopathies: A tale of two proteins

@article{Galpern2006InterfaceBT,
  title={Interface between tauopathies and synucleinopathies: A tale of two proteins},
  author={Wendy R. Galpern and Anthony E. Lang},
  journal={Annals of Neurology},
  year={2006},
  volume={59}
}
Neurodegenerative diseases are often classified based on the abnormal accumulation of synuclein or tau. Traditionally, these disorders have been viewed as distinct clinical and pathological entities. However, advances in molecular genetics and protein biochemistry have shown intriguing overlaps. The most common synucleinopathy, Parkinson's disease, is characterized by extrapyramidal motor dysfunction, whereas the most common tauopathy, Alzheimer's disease, is defined by dementia. Yet there is… 

The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease

Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders

TLDR
Evidence increasingly indicates considerable overlap between synucleinopathies and tauopathies or other protein-misfolding diseases, suggesting a dualism or triad of neurodegeneration in protein- misfolding disorders, although the etiology of most of these processes is still mysterious.

Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia

TLDR
Animal models and in vitro studies showing co-occurrence and mutual promotion of fibrillation of these proteins indicate their synergistic interactions in the pathogenesis of these disorders which, at least in part, are genetically influenced.

Alpha-synuclein and tau: teammates in neurodegeneration?

TLDR
It is suggested that interactions between tau and α-synuclein form a deleterious feed-forward loop essential for the development and spreading of neurodegeneration.

Regional Overlap of Pathologies in Lewy Body Disorders

TLDR
Pathological stages of tau, β-amyloid and α-synuclein pathologies were increased in cases with dementia, and common concurrence of pathologies in patients with LBD that may have an impact on the clinical expression of the diseases.

The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?

Progressive supranuclear palsy phenotype mimicking synucleinopathies

Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau

TLDR
The role of tau in the pathogenesis of LBDs is distinct from AD, and Lewy pathology formation may be independent of endogenous tau, according to Recombinant α-synuclein and tau proteins interact in vitro.
...

References

SHOWING 1-10 OF 145 REFERENCES

alpha-Synuclein is phosphorylated in synucleinopathy lesions.

TLDR
It is shown by mass spectrometry analysis and studies with an antibody that specifically recognizes phospho-Ser 129 of alpha-synuclein, that this residue is selectively and extensively phosphorylated in synucleinopathy lesions and promoted fibril formation in vitro.

α-Synuclein is phosphorylated in synucleinopathy lesions

TLDR
It is shown by mass spectrometry analysis and studies with an antibody that specifically recognizes phospho-Ser 129 of α-synuclein, that this residue is selectively and extensively phosphorylated in synucleinopathy lesions and promoted fibril formation in vitro.

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

TLDR
Dementia with Lewy bodies is related to mutation of α‐synuclein, and the novel mutation, that substitutes a dicarboxylic amino acid, glutamic acid, with a basic amino acid in a much conserved area of the protein, is likely to produce severe disturbance of protein function.

Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam.

TLDR
The amygdala may be selectively vulnerable to developing both tau and alpha-synuclein pathology or tau pathology may predispose it to synuclein aggregation, thereby implicating the aggregation of these molecules in the severe neurodegeneration frequently observed in this location.

Lewy body-related α-synucleinopathy in the aged human brain

  • K. Jellinger
  • Biology, Medicine
    Journal of Neural Transmission
  • 2004
TLDR
The findings largely confirm Braak’s staging of LB-pathology in PD and suggest morphologic and pathogenic relations between PD (brainstem type) and DLB with and without coexistent AD pathology.

Lewy body-related alpha-synucleinopathy in the aged human brain.

  • K. Jellinger
  • Biology, Psychology
    Journal of neural transmission
  • 2004
TLDR
The basic mechanisms of LB-related AS-pathology and their pathogenic and clinical relevance in aged brain and neurodegenerative disorders await further elucidation, suggesting morphologic similarities betwee these disorders.

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

TLDR
The biochemical characteristics of the additional, higher molecular mass species of phosphorylated alpha-synuclein-positive polypeptides that also are recovered in the Sarkosyl-insoluble fraction of synucleinopathy and migrate at about 22 and 29 kDa strongly suggest that phosphorylations are targeted to mono- and diubiquitination in syn nucleinopathy brains, which may have implications for mechanisms of these diseases.

α-Synuclein in Familial Alzheimer Disease: Epitope Mapping Parallels Dementia With Lewy Bodies and Parkinson Disease

TLDR
These findings support the hypothesis that the mechanism of α-synuclein aggregation is the same within cell types but distinctive between cell types, and suggest that the epitope profiles in LBs are similar, regardless of whether the biological trigger is related to synuclein or a different genetic pathway.
...